212 related articles for article (PubMed ID: 24836070)
1. Benzofuran derivatives as anticancer inhibitors of mTOR signaling.
Salomé C; Ribeiro N; Chavagnan T; Thuaud F; Serova M; de Gramont A; Faivre S; Raymond E; Désaubry L
Eur J Med Chem; 2014 Jun; 81():181-91. PubMed ID: 24836070
[TBL] [Abstract][Full Text] [Related]
2. Benzofuran derivatives as a novel class of inhibitors of mTOR signaling.
Salomé C; Narbonne V; Ribeiro N; Thuaud F; Serova M; de Gramont A; Faivre S; Raymond E; Désaubry L
Eur J Med Chem; 2014 Mar; 74():41-9. PubMed ID: 24445311
[TBL] [Abstract][Full Text] [Related]
3. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV
Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.
Bazin MA; Bodero L; Tomasoni C; Rousseau B; Roussakis C; Marchand P
Eur J Med Chem; 2013 Nov; 69():823-32. PubMed ID: 24121233
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds.
Huang Q; Xie L; Chen X; Yu H; Lv Y; Huang X; Ying J; Zheng C; Cheng Y; Huang J
Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800123. PubMed ID: 30357890
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-cancer activity evaluation of new aurone derivatives.
Demirayak S; Yurttas L; Gundogdu-Karaburun N; Karaburun AC; Kayagil I
J Enzyme Inhib Med Chem; 2015; 30(5):816-25. PubMed ID: 25716125
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anticancer activity of novel hybrid compounds between benzofuran and N-aryl piperazine.
Mao ZW; Zheng X; Lin YP; Hu CY; Wang XL; Wan CP; Rao GX
Bioorg Med Chem Lett; 2016 Aug; 26(15):3421-4. PubMed ID: 27371110
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Rapamycin Derivatives Containing the Triazole Moiety Used as Potential mTOR-Targeted Anticancer Agents.
Xie L; Huang J; Chen X; Yu H; Li K; Yang D; Chen X; Ying J; Pan F; Lv Y; Cheng Y
Arch Pharm (Weinheim); 2016 Jun; 349(6):428-41. PubMed ID: 27150260
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 21-alkynylaryl pregnenolone derivatives and evaluation of their anticancer activity.
Szalóki G; Pantzou A; Prousis KC; Mavrofrydi O; Papazafiri P; Calogeropoulou T
Bioorg Med Chem; 2014 Dec; 22(24):6980-8. PubMed ID: 25456391
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Leucyladenylate Sulfamates as Novel Leucyl-tRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitors.
Yoon S; Kim JH; Kim SE; Kim C; Tran PT; Ann J; Koh Y; Jang J; Kim S; Moon HS; Kim WK; Lee S; Lee J; Kim S; Lee J
J Med Chem; 2016 Nov; 59(22):10322-10328. PubMed ID: 27933890
[TBL] [Abstract][Full Text] [Related]
12. Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors.
Mortensen DS; Perrin-Ninkovic SM; Harris R; Lee BG; Shevlin G; Hickman M; Khambatta G; Bisonette RR; Fultz KE; Sankar S
Bioorg Med Chem Lett; 2011 Nov; 21(22):6793-9. PubMed ID: 21978683
[TBL] [Abstract][Full Text] [Related]
13. N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells.
Wang M; Zhou A; An T; Kong L; Yu C; Liu J; Xia C; Zhou H; Li Y
J Exp Clin Cancer Res; 2016 Mar; 35():41. PubMed ID: 26940018
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
[TBL] [Abstract][Full Text] [Related]
15. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.
Xia Y; Jin Y; Kaur N; Choi Y; Lee K
Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines.
Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC
Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505
[TBL] [Abstract][Full Text] [Related]
17. Different cytotoxicities and cellular localizations of novel quindoline derivatives with or without boronic acid modifications in cancer cells.
Yin R; Zhang M; Hao C; Wang W; Qiu P; Wan S; Zhang L; Jiang T
Chem Commun (Camb); 2013 Oct; 49(76):8516-8. PubMed ID: 23942773
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran-pyrazole derivatives as anticancer agents.
Abd El-Karim SS; Anwar MM; Mohamed NA; Nasr T; Elseginy SA
Bioorg Chem; 2015 Dec; 63():1-12. PubMed ID: 26368040
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
Choi M; Jo H; Park HJ; Sateesh Kumar A; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
Bioorg Med Chem Lett; 2015 Jun; 25(12):2545-9. PubMed ID: 25953156
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl)benzo[d]thiazol-2-yl)urea as anticancer agents with low toxicity.
Xie XX; Li H; Wang J; Mao S; Xin MH; Lu SM; Mei QB; Zhang SQ
Bioorg Med Chem; 2015 Oct; 23(19):6477-85. PubMed ID: 26321603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
